JETEMA, Co., Ltd. (KOSDAQ:216080)
4,855.00
+15.00 (0.31%)
Jun 12, 2026, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 181.03 billion as of June 12, 2026. Its market cap has decreased by -28.26% in one year.
Market Cap
181.03B
Enterprise Value
291.44B
Revenue
77.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,855.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 181.03B, an increase of 40.22%. That is a compound annual growth rate of 5.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 181.03B | -17.85% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 250.00B |
| Anterogen.Co.,Ltd. | 246.65B |
| GC Cell | 244.94B |
| HLB Therapeutics | 231.41B |
| EASY BIO,Inc. | 217.35B |
| Helixmith | 205.83B |
| Bioneer | 196.42B |
| NeoImmuneTech | 174.70B |